Trial NCT04972253

View at ClinicalTrials.gov 
Org. Study IDs: 21-162

Last trial update was posted on 2022-08-10

MeSH Interventions

Infigratinib

MeSH Conditions

Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Bladder Cancer Bladder Transitional Cell Carcinoma Fibroblast Growth Factor Receptor

Stopping Reasons

Low Accrual

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID